Bio-Rad Labs (NYSE: BIO) reported Q1 EPS of $1.65, $0.55 better than the analyst estimate of $1.10. Revenue for the quarter came in at $554 million versus the consensus estimate of $549.56 million.

For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.